ENTRY       D02749                      Drug
NAME        Teceleukin (USAN);
            Teceleukin (genetical recombination) (JP18);
            Imunace (TN)
FORMULA     C698H1127N179O204S8
EXACT_MASS  15537.1082
MOL_WEIGHT  15547.0139
SEQUENCE    MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL
            EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN
            RWITFCQSII STLT (Disulfid bridge: 59-106)
  TYPE      Peptide
REMARK      Therapeutic category: 6399
            Product: D02749<JP>
EFFICACY    Antineoplastic, Immunostimulant, Biological response modifier
COMMENT     recombinant interleukin 2 [HSA:3558] [KO:K05429]
TARGET      IL2RA (CD25) [HSA:3559] [KO:K05068]
            IL2RB (CD122) [HSA:3560] [KO:K05069]
            IL2RG (CD132) [HSA:3561] [KO:K05070]
  PATHWAY   hsa04060(3559+3560+3561)  Cytokine-cytokine receptor interaction
            hsa04630(3559+3560+3561)  JAK-STAT signaling pathway
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               639  Miscellaneous
                6399  Others
                 D02749  Teceleukin (USAN); Teceleukin (genetical recombination) (JP18)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL2RA (CD25)
                 D02749  Teceleukin (USAN) &lt;JP&gt;
                IL2RB (CD122)
                 D02749  Teceleukin (USAN) &lt;JP&gt;
                IL2RG (CD132)
                 D02749  Teceleukin (USAN) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D02749  Teceleukin (genetical recombination)
              D02749  Teceleukin for injection (genetical recombination)
DBLINKS     CAS: 136279-32-8
            PubChem: 47205821
///
